It also has expanded the number of diseases and disorders that merit an immediate review, which include acute leukemia and pancreatic cancer, to 113, from 100.
Those groups argue that the treatment and the potential side effects -- such as memory loss and brain damage -- are serious enough to merit a thorough review.